Importantly, the suppressive activity of Tregs by STAT5 overexpression in DCs could enhance tumorigenicity, and therefore, beta cell antigen-specific Tregs endowed with highly suppressive function are suitable for T1D treatment. Here, STAT5B is linked to type 1 diabetes mellitus.